
The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas.
KJ Muldoon is walking and getting ready to celebrate the holiday season at home with his parents and three siblings.
KJ was born last year with a genetic disorder called carbamoyl-phosphate synthetase 1 deficiency. Also known as CPS1 deficiency, the metabolic condition affects only 1 in 1.3 million babies and often leads to life-threatening outcomes.
When he was 6 months old, doctors began giving KJ a groundbreaking new treatment -- a personalized CRISPR gene editing therapy at Children's Hospital of Philadelphia.
Doctors save baby's life with first-ever gene fix for deadly rare disease
The gene-editing therapy works like a "molecular spell-checker,” finding and fixing the specific genetic error causing his condition.
After three infusions and after spending the first 10 months of his life in a hospital, KJ was discharged and sent home in June.
Baby saved by gene-editing therapy 'graduates' from hospital, goes home
Since then, KJ has continued to grow and thrive with his family, celebrating his first birthday at home and taking part in one of the family’s favorite rituals -- cheering for their beloved Philadelphia Eagles.
Doctors hope new technology like CRISPR gene-editing therapies can be the key to treating more than 7,000 rare diseases, such as sickle cell disease, cystic fibrosis, Huntington’s disease and muscular dystrophy, that affect approximately 30 million people across the country.
LATEST POSTS
- 1
Top 5 Top of the line Books of the Year - 2
Artemis 2 astronauts head for the moon after make-or-break engine burn (video) - 3
Figure out How to Pick a Crematorium: Key Contemplations. - 4
I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us. - 5
Jamaica reports deadly leptospirosis outbreak after Hurricane Melissa
Netflix Faces Wider Fallout After Italy Court Orders Refunds, Price Cuts
Cyber Monday 2025: Save over 70% on HBO Max with this Prime Video streaming deal
Russian authorities threaten WhatsApp with total ban
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials
What's going around right now? COVID, flu, stomach bug on the rise
Instructions to Expand Your Advantages from an Open Record Reward
Cocoa Prices Undercut Amid the Prospects of Abundant Supplies
Senegal limits foreign trips for officials as the fallout from Iran war deepens
Help Your Business with Master Web based Promoting Arrangements











